Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Reproductive endocrinology

Oral enclomiphene citrate in obese men with hypogonadism

Nature Reviews Urology volume 13, pages 133–134 (2016)Cite this article

Subjects

Testosterone supplementation therapy is an effective therapy for hypogonadism but can lead to the suppression of spermatogenesis. A new study investigated the effects of enclomiphene citrate, the trans isomer of clomiphene, on serum hormone levels and sperm counts in men with secondary hypogonadism.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mulligan, T., Frick, M. F., Zuraw, Q. C., Stemhagen, A. & McWhirter, C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int. J. Clin. Pract. 60, 762–769 (2006).

    Article  CAS  Google Scholar 

  2. Pan, M., Ramasamy, R. & Kovac, J. R. Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age? Can. Urol. Assoc. J. 8, 446–447 (2014).

    Article  Google Scholar 

  3. Huang, E. S. & Miller, W. L. Estrogenic and antiestrogenic effects of enclomiphene and zuclomiphene on gonadotropin secretion by ovine pituitary cells in culture. Endocrinology 112, 442–448 (1983).

    Article  CAS  Google Scholar 

  4. Wiehle, R. et al. Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics. BJU Int. http://dx.doi.org/10.1111/bju.12363 (2013).

  5. Kim, E. D., McCullough, A. & Kaminetsky, J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU Int. http://dx.doi.org/10.1111/bju.13337 (2015).

  6. Ramasamy, R., Scovell, J. M., Kovac, J. R. & Lipshultz, L. I. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. J. Urol. 192, 875–879 (2014).

    Article  CAS  Google Scholar 

  7. Moskovic, D. J., Katz, D. J., Akhavan, A., Park, K. & Mulhall, J. P. Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU Int. 110, 1524–1528 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jason R. Kovac is at the Men's Health Center, Urology of Indiana, 8240 Naab Road, Suite 200, Indianapolis, Indiana 46260, USA.,

    Jason R. Kovac

Authors
  1. Jason R. Kovac
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason R. Kovac.

Ethics declarations

Competing interests

J.R.K. declares that he is a member of the speakers' bureau for AbbVie.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kovac, J. Oral enclomiphene citrate in obese men with hypogonadism. Nat Rev Urol 13, 133–134 (2016). https://doi.org/10.1038/nrurol.2015.311

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2015.311

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing